Gemcitabine as single agent in the treatment of relapsed or refractory aggressive non-Hodgkin lymphoma (NHL)

被引：0
|
作者：
Welt, A [1 ]
Fossa, A [1 ]
Blatter, J [1 ]
Buksmaui, S [1 ]
Seeber, S [1 ]
Nowrousian, MR [1 ]
机构：
[1] Univ Essen, Lilly Deutschland, W German Canc Ctr, Dept Med Oncol Canc Res, Bad Homburg, Germany
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
643
引用
收藏
页码：168 / 168
页数：1
相关论文
共 50 条
  • [21] Pixantrone: A Review in Relapsed or Refractory Aggressive Non-Hodgkin’s Lymphoma
    Gillian M. Keating
    Drugs, 2016, 76 : 1579 - 1586
  • [22] Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
    Wiernik, Peter H.
    Lossos, Izidore S.
    Tuscano, Joseph M.
    Justice, Glen
    Vose, Julie M.
    Cole, Craig E.
    Lam, Wendy
    McBride, Kyle
    Wride, Kenton
    Pietronigro, Dennis
    Takeshita, Kenichi
    Ervin-Haynes, Annette
    Zeldis, Jerome B.
    Habermann, Thomas M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) : 4952 - 4957
  • [23] Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin's lymphoma
    Weidmann, E
    Kim, SZ
    Rost, A
    Schuppert, H
    Seipelt, G
    Hoelzer, D
    Mitrou, PS
    ANNALS OF ONCOLOGY, 2002, 13 (08) : 1285 - 1289
  • [24] Conditioning with Treosulfan and Fludarabine for Patients with Refractory or Relapsed Non-Hodgkin Lymphoma (NHL)
    Schmitt, Michael
    Trenschel, Rudolf
    Sayer, Herbert G.
    Schneider, Catarina
    Glass, Aenne
    Hilgendorf, Inken
    Treschl, Anne
    Junghanss, Christian
    Borchert, Kersten
    Koenigsmann, Michael
    Casper, Jochen
    Beelen, Dietrich
    Freund, Mathias
    Kahl, Christoph
    BLOOD, 2011, 118 (21) : 1753 - 1753
  • [25] Pixantrone: A Review in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
    Keating, Gillian M.
    DRUGS, 2016, 76 (16) : 1579 - 1586
  • [26] Activity of vinorelbine/gemcitabine in relapsed/refractory Hodgkin's and non-Hodgkin's lymphoma
    不详
    CLINICAL LYMPHOMA, 2003, 3 (04): : 207 - 208
  • [27] Clofarabine (CLO) Has Single Agent Activity in Relapsed and Refractory Non-Hodgkin Lymphoma (NHL) Including Rituximab (R)-Refractory Patients (pts)
    Nabhan, Chadi
    Bitran, Jacob David
    Fried, Walter
    Galvez, Angel G.
    Magid, Laura
    Tolzien, Kathy
    Dewey, Wendy
    Venugopal, Parameswaran
    BLOOD, 2009, 114 (22) : 380 - 380
  • [28] Efficacy and safety of gemcitabine containing regimen for refractory and relapsed non-Hodgkin lymphoma
    Mizutani, Chisato
    Nishi, Katsuyuki
    Takahashi, Satoshi
    Mitani, Sachiko
    Tada, Kohei
    Kaneko, Hitomi
    Hatanaka, Kazuo
    Ukyo, Naoya
    Hirata, Hirokazu
    Tsudo, Mituru
    ANNALS OF ONCOLOGY, 2015, 26 : 147 - 147
  • [29] Daunoxome in the treatment of relapsed/refractory low grade and intermediate grade non-Hodgkin's lymphoma (NHL)
    Tulpule, A
    Rarick, MU
    Kolitz, J
    Bernstein, J
    HarveyBuchanan, L
    Espina, BM
    Trader, G
    Mukwaya, G
    Onetto, N
    Gill, PS
    Levine, AM
    BLOOD, 1997, 90 (10) : 846 - 846
  • [30] Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
    Younes, A
    Preti, HA
    Hagemeister, FB
    McLaughlin, P
    Romaguera, JE
    Rodriguez, MA
    Samuels, BI
    Palmer, JL
    Cabanillas, F
    ANNALS OF ONCOLOGY, 2001, 12 (07) : 923 - 927
12345